Quadrature Capital’s Zimmer Biomet ZBH Stock Holding History

Quadrature Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,795	Closed	-$303K	–	1454
2024 Q2	$303K	Buy	+2,795	New	+$329K	0.01%	824
2024 Q1	–	Sell	-20,169	Closed	-$2.45M	–	1544
2023 Q4	$2.45M	Sell	20,169 -17,120	-46%	-$1.91M	0.04%	222
2023 Q3	$4.19M	Buy	37,289 +28,065	+304%	+$3.56M	0.09%	168
2023 Q2	$1.34M	Buy	+9,224	New	+$1.25M	0.03%	358
2022 Q1	–	Sell	-8,585	Closed	-$1.06M	–	1009
2021 Q4	$1.06M	Buy	+8,585	New	+$1.12M	0.06%	222
2021 Q3	–	Sell	-6,906	Closed	-$1.08M	–	1104
2021 Q2	$1.08M	Buy	+6,906	New	+$1.12M	0.04%	298
2020 Q3	–	Sell	-8,961	Closed	-$1.04M	–	947
2020 Q2	$1.04M	Buy	+8,961	New	+$1.03M	0.12%	248
2020 Q1	–	Sell	-70,791	Closed	-$10.3M	–	739
2019 Q4	$10.3M	Buy	+70,791	New	+$9.77M	0.39%	82
2016 Q3	–	Sell	-64,113	Closed	-$7.49M	–	764
2016 Q2	$7.49M	Buy	+64,113	New	+$7.26M	0.56%	42
2015 Q4	–	Sell	-2,927	Closed	-$267K	–	540
2015 Q3	$267K	Buy	+2,927	New	+$293K	0.09%	227

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Quadrature Capital's ZBH Position: Q3 2024 in Review

Quadrature Capital sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,795 shares — an estimated $303K sold.

Quadrature Capital first reported a position in ZBH in Q3 2015 and held it in 10 quarters. The position peaked at $10.3M in Q4 2019. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Quadrature Capital reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Quadrature Capital sold 2,795 Zimmer Biomet shares in Q3 2024, an estimated $303K.
Quadrature Capital first reported a position in Zimmer Biomet in Q3 2015 and held it in 10 quarters.
Quadrature Capital's Zimmer Biomet position peaked at $10.3M in Q4 2019.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Quadrature Capital's 13F filing for Q3 2024, filed 14 Nov 2024.